Oncoinvent ASA
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol ONCIN:xosl
Currency NOK
Oslo Børs/Oslo Stock Exchange
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Oncoinvent ASA
Oncoinvent ASA is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The product candidate, Radspherin, uses the alpha-emitting radionuclide radium-224 to directly target micrometastases post-surgery, harnessing the benefits of modern radiopharmaceuticals without the complexities of biological targeting.
Sector Healthcare
Industry Oncology Biopharmaceuticals
Market Cap 0.118248291bn
Data provided by 
/ 
/ Others were interested in
This information is not currently available for this instrument. Refresh the page or try again later.